Catalyst Wire Dossier Catalyst Wire Dossier

idarubicin and cytarabine (standard regimen)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for idarubicin and cytarabine (standard regimen), covering 2018-06-12 to 2018-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) [Phase 2]

See pricing